Real-World Study of PADN for the Treatment of PAH

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorPulnovo Medical (Wuxi) Co., Ltd.

About this trial

Real-World Study of PADN for the Treatment of PAH

Eligibility criteria

Qualifiers

Diagnosed with PAH and received PADN procedure since March 2024.

No contraindications to procedure.

Able to provide informed consent and authorize use of health/research data.

Compliant with treatment and follow-up requirements.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Enhancor™ Radiofrequency Catheter, Pulnovo Medical (Wuxi) CO., Ltd., Wuxi, Jiangsu, China

Treatment groups

No treatment groups listed